• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

Menopause linked to decreased anti-HIV activity

byDenise PongandLeah Carr, MD
March 29, 2015
in Infectious Disease, Obstetrics
Reading Time: 2 mins read
Use of injectable contraceptive, Depo-Provera, linked to increased risk of HIV
Share on FacebookShare on TwitterShare on LinkedIn

1. Postmenopausal women’s cervicovaginal fluid had lower anti-HIV-1 activity than premenopausal women.

2. Timing of menstrual cycle and hormonal contraception were not associated with differences in activity against HSV or HIV.

Evidence Rating Level: 3 (Average)    

Study Rundown: Among older individuals, lack of safe sex education, delayed or absent screening by healthcare providers, declining immune systems, and improved treatment of chronic conditions including HIV have contributed to an increase in sexually transmitted infection prevalence.  In women, cervicovaginal fluid provides first-line defense against pathogens. However, after menopause, the immune function of the lower genital tract declines. Specifically, the vaginal epithelium becomes thinner, while mucus production and antimicrobial activity decrease. Prior studies have shown changes in immune factors among women using different hormonal contraceptive methods and postmenopausal women. In the current study, the authors sought to evaluate the effect of endogenous and exogenous hormones on antiviral activity of vaginal fluid and found that anti-HIV-1 activity was decreased in postmenopausal women. This finding suggests that postmenopausal women are at increased risk of acquiring HIV; barrier methods and screening for those at-risk should be encouraged by providers.

Strengths of the study included evaluation of both endogenous and exogenous hormone impact on antiviral activity and blinding of those performing laboratory tests. Limitations included the cross-sectional design of the study and inclusion of few postmenopausal women. Additional large prospective studies are needed to better characterize the changes in antiviral activity that occur during and after menopause.

Click to read the study in the AJOG (American Journal of Obstetrics and Gynecology)

RELATED REPORTS

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

Relevant Reading: Innate immunity of the human female reproductive tract- endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections

Study Author, Dr. Catherine Chappell, MD, talks to 2 Minute Medicine: Magee-Womens Hospital of the University Pittsburgh Medical Center, Fellow in Family Planning and Reproductive Infectious Disease, Department of Obstetrics, Gynecology and Reproductive Sciences. 

“Postmenopausal women may be at increased risk for HIV-1 acquisition and should be counseled to use barrier protection if they are at risk for contracting sexually transmitted infections. Future research should focus on which immune factors are hormonally regulated and may contribute to enhanced HIV-1 risk in postmenopausal women.”

FDA approvedFor HIV: Idvynso (doravirine and islatravir), Apr 20, 2026→

In-Depth [cross-sectional study]: This study evaluated the impact of endogenous and exogenous hormones on antiviral activity in cervicovaginal lavage in premenopausal women ages 18-46 not using exogenous hormones in days 1-14 (n = 26) or 15-28 (n = 27) of their menstrual cycle, women using combined oral contraceptives (n=27), women using medroxyprogesterone acetate (n = 28), levonorgestrel IUD (n = 28), and postmenopausal women ages >50 years (n = 29). Outcomes of interest were cervicovaginal lavage anti-HIV-1, anti-HSV-1 and anti-HSV-2 activity, and protein content.

Cervicovaginal lavage from postmenopausal women had lower protein levels (p < 0.001) and lower anti-HIV-1 activity than that from premenopausal women (p = 0.002). Protein content was positively correlated with anti-HIV-1 activity (r = 0.44, p < 0.001).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: HIVmenopausesexually transmitted infections
Previous Post

Exercise decreases risk of injurious falls in elderly women

Next Post

AAP opposes school-based drug testing of adolescents

RelatedReports

An illustration showing a brain scan alongside a human brain, symbolizing brain health and cognitive decline.
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
A circular calendar divided into sections, with a blue pill resting on one section and representations of HIV particles surrounding it, symbolizing HIV treatment adherence.
Chronic Disease

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

September 24, 2026
HIV care collage: a smiling middle-aged man with an awareness ribbon pinned to his shirt beside a sprig of olive leaves
Infectious Disease

Maternal engagement in HIV care associated with pediatric viral suppression

August 28, 2026
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Chronic Disease

Early menarche and later menopause are associated with increased ovarian cancer risk

February 13, 2026
Next Post

AAP opposes school-based drug testing of adolescents

Motivational interviewing and dietary counseling reduce BMI

USPSTF finds inconclusive evidence for routine iron screening and supplementation in pregnancy

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer
  • AI health chatbot shows no benefit for perinatal anxiety or depression
  • ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.